Skin Burns Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight

Globe and Mail

12-03-2025

Skin Burns companies are Smith+Nephew, Mölnlycke Health Care AB, Convatec Inc., 3M, Coloplast Group, Medtronic, Accell Group, Anika Therapeutics, Inc., B. Braun Melsungen AG, Cardinal Health, DeRoyal Industries, Hollister, Integra LifeSciences Corporation, Medline Industries, Inc., PAUL HARTMANN AG, Essity Aktiebolag, Avita Medical, Suwelack Skin and Health Care AG, Healthpoint, Fort Worth, Advanced BioHealing, Mallinckrodt, RenovaCare, among others.
(Albany, USA) DelveInsight's " Skin Burns Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Skin Burns market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Skin Burns market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Skin Burns treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Skin Burns market.
Some facts of the Skin Burns Market Report are:
According to DelveInsight, Skin Burns market size is expected to grow at a decent CAGR by 2034.
Leading Skin Burns companies working in the market are Smith+Nephew, Mölnlycke Health Care AB, Convatec Inc., 3M, Coloplast Group, Medtronic, Accell Group, Anika Therapeutics, Inc., B. Braun Melsungen AG, Cardinal Health, DeRoyal Industries, Hollister, Integra LifeSciences Corporation, Medline Industries, Inc., PAUL HARTMANN AG, Essity Aktiebolag, Avita Medical, Suwelack Skin and Health Care AG, Healthpoint, Fort Worth, Advanced BioHealing, Mallinckrodt, RenovaCare, among others.
Key Skin Burns Therapies expected to launch in the market are NexoBrid/KMW-1, Kerecis Omega3, StrataGraft, MW-III, DenovoSkin (EHSG-KF), and many others.
In August 2024, Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for NexoBrid® (anacaulase-bcdb) for eschar removal in pediatric patients with deep partial-thickness and/or full-thickness thermal burns.
In May 2024, AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the RECELL GO™ System, its next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient's own skin to treat thermal burn wounds and full-thickness skin defects.
Skin Burns Overview
Skin burns are tissue injuries caused by heat, chemicals, electricity, radiation, or friction, leading to cell damage, inflammation, and potential complications. Burns are classified into three main degrees based on severity:
First-degree burns affect only the epidermis, causing redness, pain, and mild swelling (e.g., sunburns).
Second-degree burns extend into the dermis, resulting in blisters, intense pain, and risk of infection.
Third-degree burns damage all skin layers, potentially affecting nerves, muscles, and bones, leading to numbness, scarring, and permanent tissue loss.
Burns can be thermal (fire, hot liquids, steam), chemical (acids, alkalis), electrical (high-voltage exposure), or radiation-induced (UV exposure, radiation therapy). The severity depends on burn depth, percentage of total body surface area (TBSA) affected, and location.
Skin burns Treatment varies based on burn severity. Minor burns require cooling, wound care, pain management, and topical antibiotics, while severe burns necessitate hospitalization, intravenous fluids, infection control, debridement, skin grafts, and reconstructive surgery. Advanced therapies, including stem cell treatments, bioengineered skin substitutes, and regenerative medicine, are improving recovery outcomes. Early intervention, proper wound management, and multidisciplinary care are essential in minimizing scarring, functional impairment, and long-term complications in burn patients.
Do you know what will be the Skin Burns market share in 7MM by 2034 @ Skin Burns Treatment Market
Skin Burns Market
The Skin Burns market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Skin Burns market trends by analyzing the impact of current Skin Burns therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Skin Burns market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Skin Burns market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The skin burns market is driven by rising burn injuries globally, advancements in wound care technologies, and increasing awareness of specialized burn treatments. The growing incidence of thermal, chemical, and electrical burns, particularly in industrial settings, household accidents, and conflict zones, is fueling demand for advanced burn care products. Innovations in bioengineered skin substitutes, stem cell therapy, and regenerative medicine have significantly improved burn healing and scar reduction. Additionally, government initiatives, improved healthcare infrastructure, and reimbursement policies are supporting market expansion. The increasing use of hydrocolloid dressings, antimicrobial wound care, and skin grafting procedures is further enhancing patient outcomes.
However, the market faces barriers such as high treatment costs, limited access to advanced therapies in developing regions, and the risk of infections and complications. Severe burns require specialized treatment centers, which are not always available, leading to delayed or inadequate care. Additionally, stringent regulatory approvals for new burn treatments, variability in insurance coverage, and challenges in developing cost-effective solutions hinder market growth. Despite these challenges, ongoing research into novel wound healing technologies, autologous cell-based therapies, and nanotechnology-based dressings is expected to drive innovation and improve the future landscape of the skin burns treatment market.
According to DelveInsight, the Skin Burns market in 7MM is expected to witness a major change in the study period 2020-2034.
Skin Burns Epidemiology
The Skin Burns epidemiology section provides insights into the historical and current Skin Burns patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Skin Burns market report also provides the diagnosed patient pool, trends, and assumptions.
Interested to know how the emerging diagnostic approaches will be contributing in increased Skin Burns diagnosed prevalence pool? Download report @ Skin Burns Epidemiology Forecast
Skin Burns Drugs Uptake
This section focuses on the uptake rate of the potential Skin Burns drugs recently launched in the Skin Burns market or expected to be launched in 2020-2034. The analysis covers the Skin Burns market uptake by drugs, patient uptake by therapies, and sales of each drug.
Skin Burns Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Skin Burns market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Skin Burns Pipeline Development Activities
The Skin Burns report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Skin Burns key players involved in developing targeted therapeutics.
Download report to know which TOP 3 therapies will be capturing the largest Skin Burns market share by 2034? Click here @ Skin Burns Medication and Companies
Skin Burns Therapeutics Assessment
Major key companies are working proactively in the Skin Burns Therapeutics market to develop novel therapies which will drive the Skin Burns treatment markets in the upcoming years are Smith+Nephew, Mölnlycke Health Care AB, Convatec Inc., 3M, Coloplast Group, Medtronic, Accell Group, Anika Therapeutics, Inc., B. Braun Melsungen AG, Cardinal Health, DeRoyal Industries, Hollister, Integra LifeSciences Corporation, Medline Industries, Inc., PAUL HARTMANN AG, Essity Aktiebolag, Avita Medical, Suwelack Skin and Health Care AG, Healthpoint, Fort Worth, Advanced BioHealing, Mallinckrodt, RenovaCare, among others.
Do you know how new drug market launch will be impacting the Skin Burns market CAGR? Download sample report @ Skin Burns Clinical Trials and Therapeutic Assessment
Skin Burns Report Key Insights
1. Skin Burns Patient Population
2. Skin Burns Market Size and Trends
3. Key Cross Competition in the Skin Burns Market
4. Skin Burns Market Dynamics (Key Drivers and Barriers)
5. Skin Burns Market Opportunities
6. Skin Burns Therapeutic Approaches
7. Skin Burns Pipeline Analysis
8. Skin Burns Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Skin Burns Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Skin Burns Competitive Intelligence Analysis
4. Skin Burns Market Overview at a Glance
5. Skin Burns Disease Background and Overview
6. Skin Burns Patient Journey
7. Skin Burns Epidemiology and Patient Population
8. Skin Burns Treatment Algorithm, Current Treatment, and Medical Practices
9. Skin Burns Unmet Needs
10. Key Endpoints of Skin Burns Treatment
11. Skin Burns Marketed Products
12. Skin Burns Emerging Therapies
13. Skin Burns Seven Major Market Analysis
14. Attribute Analysis
15. Skin Burns Market Outlook (7 major markets)
16. Skin Burns Access and Reimbursement Overview
17. KOL Views on the Skin Burns Market
18. Skin Burns Market Drivers
19. Skin Burns Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: [phone]
Address: 304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting